Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4

Dapito, Dianne H., Mencin, Ali, Gwak, Geum-Youn, Pradere, Jean-Philippe, Jang, Myoung-Kuk, Mederacke, Ingmar, Caviglia, Jorge M., Khiabanian, Hossein +8 more·2012·Cancer Cell
DOI 10.1016/j.ccr.2012.02.007

Cited by (1,000)

Items 101–200 of 1,000

  1. NAFLD‐related hepatocellular carcinoma: The growing challenge
    Pir Ahmad Shah, Rashmee Patil, Stephen A. Harrison · 2022 · Hepatology
  2. Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma
    Yujin Hoshida, Bryan C. Fuchs, Nabeel M. Bardeesy, Thomas F. Baumert, Raymond T. Chung · 2014 · Journal of Hepatology
  3. Gut microbial profile analysis by MiSeq sequencing of pancreatic carcinoma patients in China
    Zhigang Ren, Jianwen Jiang, Haiyang Xie, Ang Li, Haifeng Lu, Shaoyan Xu, Lin Zhou, Hua Zhang, Guangying Cui, Xinhua Chen et al. · 2017 · Oncotarget
  4. Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer
    Konstantina Georgila, Dimitra Vyrla, Elias Drakos · 2019 · Cancers
  5. Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment
    Schneider, Kai Markus, Mohs, Antje, Gui, Wenfang, Galvez, Eric J. C., Candels, Lena Susanna, Hoenicke, Lisa, Muthukumarasamy, Uthayakumar, Holland, Christian H., Elfers, Carsten, Kilic, Konrad et al. · 2022 · Nature Communications
  6. Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment
    Xueru Mu, Regina Español‐Suñer, Ingmar Mederacke, Silvia Affò, Rita Manco, Christine L Sempoux, Frédéric P. Lemaigre, Arlind Adili, Detian Yuan, Achim Weber et al. · 2015 · Journal of Clinical Investigation
  7. Bacterial infections and cancer
    Daphne M. van Elsland, Jacques Neefjes · 2018 · EMBO Reports
  8. Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword
    Marion Dajon, Kristina Iribarren, Isabelle Cremer · 2016 · Immunobiology
  9. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells
    Sarang Tartey, Osamu Takeuchi · 2017 · International Reviews of Immunology
  10. Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness
    Edit Mikó, András Vida, Tündé Kovàcs, Gyula Ujlaki, György Trencsényi, Judit Márton, Zsanett Sári, Patrik Kovács, Anita Boratkó, Zoltán Hujber et al. · 2018 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
  11. Microbiota effects on cancer: From risks to therapies
    Rea, Domenica, Coppola, Giovanni, Palma, Giuseppe, Barbieri, Antonio, Luciano, Antonio, Del Prete, Paola, Rossetti, Sabrina, Berretta, Massimiliano, Facchini, Gaetano, Perdonà, Sisto et al. · 2018 · Oncotarget
  12. Inhibition of De Novo NAD + Synthesis by Oncogenic URI Causes Liver Tumorigenesis through DNA Damage
    Krishna Seshu Tummala, Ana L. Gomes, Mahmut Yilmaz, Osvaldo Graña‐Castro, Latifa Bakiri, Isabel Ruppen, Pilar Ximénez‐Embún, Vinayata Sheshappanavar, Manuel Rodriguez‐Justo, David G. Pisano et al. · 2014 · Cancer Cell
  13. Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis
    Michał Grąt, Karolina Maria Wronka, Maciej Krasnodębski, Łukasz Masior, Zbigniew Lewandowski, Irena Kosińska, Karolina Grąt, Jan Stypułkowski, Sławomir Rejowski, Michał P. Wasilewicz et al. · 2016 · Transplantation Proceedings
  14. Interactive relationships between intestinal flora and bile acids
    Guo, Xiaohua, Okpara, Edozie Samuel, Hu, Wanting, Yan, Chuyun, Wang, Yu, Liang, Qionglin, Chiang, John Y. L., Han, Shuxin · 2022 · International Journal of Molecular Sciences
  15. The role of the vaginal microbiome in gynaecological cancer
    Miriam Champer, AM Wong, Jackson Champer, Ilana Brito, Philipp W. Messer, JY Hou, JD Wright · 2017 · BJOG An International Journal of Obstetrics & Gynaecology
  16. Activation of Nrf2 signaling by natural products-can it alleviate diabetes?
    Manuel Matzinger, Katrin Fischhuber, Elke H. Heiß · 2017 · Biotechnology Advances
  17. Immune-based therapies for hepatocellular carcinoma
    David James Pinato, Nadia Guerra, Petros Fessas, Ravindhi Murphy, Takashi Mineo, Francesco Angelo Mauri, Sujit K. Mukherjee, Mark R. Thursz, Ching Ngar Wong, Rohini Sharma et al. · 2020 · Oncogene
  18. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma
    Hechen Huang, Zhigang Ren, Xingxing Gao, Xiaoyi Hu, Yuan M. Zhou, Jianwen Jiang, Haifeng Lu, Shengyong Yin, Junfang Ji, Lin Zhou et al. · 2020 · Genome Medicine
  19. Emerging Signaling Pathways in Hepatocellular Carcinoma
    Agrin Moeini, Helena Cornellà, Augusto Villanueva · 2012 · Liver Cancer
  20. Trapping of Lipopolysaccharide to Promote Immunotherapy against Colorectal Cancer and Attenuate Liver Metastasis
    Wantong Song, Karthik Tiruthani, Ying Wang, Limei Shen, Mengying Hu, Oleksandra Dorosheva, Kunyu Qiu, Karina Kinghorn, Rihe Liu, Leaf Huang · 2018 · Advanced Materials
  21. Epiregulin: Roles in normal physiology and cancer
    David J. Riese, Richard Lee Cullum · 2014 · Seminars in Cell and Developmental Biology
  22. The immunobiology of hepatocellular carcinoma in humans and mice: Basic concepts and therapeutic implications
    Jiajie Hou, Haiyan Zhang, Beicheng Sun, Michael Karin · 2019 · Journal of Hepatology
  23. Western diets and chronic diseases
    Timon Erik Adolph, Herbert Tilg · 2024 · Nature Medicine
  24. Hepatocyte autotaxin expression promotes liver fibrosis and cancer
    Eleanna Kaffe, Aggeliki Katsifa, Nikos Xylourgidis, Ioanna Ninou, Μαρκέλλα Ζαννίκου, Vaggelis Harokopos, Pelagia Foka, Alexios Dimitriadis, Kostas Evangelou, Anargyros N. Moulas et al. · 2016 · Hepatology
  25. Key Role of DAMP in Inflammation, Cancer, and Tissue Repair
    Franco Pandolfi, Simona Altamura, Simona Frosali, Pio Conti · 2016 · Clinical Therapeutics
  26. Collateral damage: Insights into bacterial mechanisms that predispose host cells to cancer
    Gagnaire, Aurélie, Nadel, Bertrand, Raoult, Didier, Neefjes, Jacques, Gorvel, Jean-Pierre · 2017 · Nature Reviews Microbiology
  27. Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis
    Matsuda, Michitaka, Seki, Ekihiro · 2020 · Seminars in Liver Disease
  28. Prebiotic-Induced Anti-tumor Immunity Attenuates Tumor Growth
    Li, Yan, Elmén, Lisa, Segota, Igor, Xian, Yibo, Tinoco, Roberto, Feng, Yongmei, Fujita, Yu, Segura Muñoz, Rafael R., Schmaltz, Robert, Bradley, Linda M. et al. · 2020 · Cell Reports
  29. Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors
    Tündé Kovàcs, Edit Mikó, András Vida, Éva Sebő, Judit Tóth, Tamás Csonka, Anita Boratkó, Gyula Ujlaki, Gréta Lente, Patrik Kovács et al. · 2019 · Scientific Reports
  30. Glioblastoma Cancer Stem Cells Evade Innate Immune Suppression of Self-Renewal through Reduced TLR4 Expression
    Alvaro G. Alvarado, Praveena Shree Thiagarajan, Erin E. Mulkearns-Hubert, Daniel J. Silver, James S. Hale, Tyler Joseph Alban, Soumya M. Turaga, Awad Jarrar, Ofer Reizes, Michelle S. Longworth et al. · 2017 · Cell stem cell
  31. The microbiome and cancer
    Goodman, Brian, Gardner, Humphrey · 2018 · The Journal of Pathology
  32. Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma
    Suki Ha, Vincent Wai‐Sun Wong, Xiang Zhang, Jun Qing Yu · 2024 · Gut
  33. β-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis
    Peri Kocabayoglu, Abigale G. Lade, Youngmin A. Lee, Ana-Cristina Dragomir, Xiaochen Sun, Maria Isabel Fiel, Swan N. Thung, Costica Aloman, Philippe M. Soriano, Yujin Hoshida et al. · 2015 · Journal of Hepatology
  34. Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management
    George T. Cholankeril, Ronak Patel, Sandeep Khurana, Sanjaya Kumar Satapathy · 2017 · World Journal of Hepatology
  35. Role of the Gut–Liver Axis in Liver Inflammation, Fibrosis, and Cancer: A Special Focus on the Gut Microbiota Relationship
    Ohtani, Naoko, Kawada, Norifumi · 2019 · Hepatology Communications
  36. New Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries
    Tejeshwar Jain, Prateek Sharma, Abhi C. Are, Selwyn Maurice Vickers, Vikas Dudeja · 2021 · Frontiers in Immunology
  37. Nonalcoholic Fatty Liver Disease, Diabetes, Obesity, and Hepatocellular Carcinoma
    Mazen Noureddin, Mary Eugenia Rinella · 2015 · Clinics in Liver Disease
  38. Nonalcoholic fatty liver disease and hepatocellular carcinoma
    Heinz Zoller, Herbert Tilg · 2016 · Metabolism
  39. Toll-like receptors in pathophysiology of liver diseases
    Şafak KIZILTAŞ · 2016 · World Journal of Hepatology
  40. Gut microbiota and liver diseases
    Masami Minemura · 2015 · World Journal of Gastroenterology
  41. Gut microbiota exaggerates triclosan-induced liver injury via gut-liver axis
    Peng Zhang, Liyang Zheng, Yitao Duan, Yuting Gao, Huihui Gao, Daqing Mao, Yi Luo · 2021 · Journal of Hazardous Materials
  42. Mouse models for liver cancer
    Latifa Bakiri, Erwin Friedrich Wagner · 2013 · Molecular Oncology
  43. Obesity-associated mechanisms of hepatocarcinogenesis
    Raffi Karagozian, Zoltán Derdák, György Baffy · 2014 · Metabolism
  44. Role of the intestinal microbiome in liver disease
    Jorge Henao‐Mejia, Eran Elinav, Christoph A. Thaiss, Paula Licona-Limón, Richard Anthony Flavell · 2013 · Journal of Autoimmunity
  45. Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease
    Alessandro Mantovani, Giovanni Targher · 2017 · Annals of Translational Medicine
  46. Signaling pathways in hepatocellular carcinoma
    Teresa García‐Lezana, Juan Luis Lopez-Canovas, Augusto Villanueva · 2020 · Advances in cancer research
  47. The Gut-Liver Axis in Health and Disease: The Role of Gut Microbiota-Derived Signals in Liver Injury and Regeneration
    Zhipeng Zheng, Baohong Wang · 2021 · Frontiers in Immunology
  48. The controversial role of Enterococcus faecalis in colorectal cancer
    Carolina Vieira De Almeida, Antonio Taddei, Amedeo Amedei · 2018 · Therapeutic Advances in Gastroenterology
  49. Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation
    Alberto Nicoletti, Francesca Romana Ponziani, Marco Biolato, Venanzio Valenza, Giuseppe Marrone, Gabriele Sganga, Antonio Gasbarrini, Luca Miele, Antonio Grieco · 2019 · World Journal of Gastroenterology
  50. Gut microbiota influence tumor development and Alter interactions with the human immune system
    Yanshan Ge, Xinhui Wang, Yali Guo, Junting Yan, Aliya Abuduwaili, Kasimujiang Aximujiang, Jie Yan, Minghua Wu · 2021 · Journal of Experimental & Clinical Cancer Research
  51. Effects of a high fat diet on intestinal microbiota and gastrointestinal diseases
    Mei Zhang, Xiao-Jiao Yang · 2016 · World Journal of Gastroenterology
  52. The Role of Short-Chain Fatty Acids and Bile Acids in Intestinal and Liver Function, Inflammation, and Carcinogenesis
    Alexander Visekruna, Maik Luu · 2021 · Frontiers in Cell and Developmental Biology
  53. Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities
    Himani Pandey, Daryl W. T. Tang, Sunny Hei Wong, Devi Lal · 2023 · Cancers
  54. Targeting the gut-liver-immune axis to treat cirrhosis
    Thomas Henry Tranah, Lindsey Ann Edwards, Bernd Schnabl, Debbie Lindsay Shawcross · 2020 · Gut
  55. Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis
    Chiu, Chien-Chao, Ching, Yung-Hao, Li, Yen-Peng, Liu, Ju-Yun, Huang, Yen-Te, Huang, Yi-Wen, Yang, Sien-Sing, Huang, Wen-Ching, Chuang, Hsiao-Li · 2017 · Nutrients
  56. Dissecting the interplay between intestinal microbiota and host immunity in health and disease: Lessons learned from germfree and gnotobiotic animal models
    Ulrike Fiebiger, Stefan Bereswill, Markus M. Heimesaat · 2016 · European Journal of Microbiology and Immunology
  57. Liver Fibrosis: From Pathogenesis to Novel Therapies
    Ralf Weiskirchen, Frank Tacke · 2016 · Digestive Diseases
  58. The gut vascular barrier: a new player in the gut–liver–brain axis
    Paola Brescia, María Rescigno · 2021 · Trends in Molecular Medicine
  59. The DEN and CCl4‐Induced Mouse Model of Fibrosis and Inflammation‐Associated Hepatocellular Carcinoma
    Takeki Uehara, Igor P. Pogribny, Ivan Rusyn · 2014 · Current Protocols in Pharmacology
  60. Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer
    Joanne Marie O’Rourke, Vandana Sagar, Tahir Shah, Shishir Shetty · 2018 · World Journal of Gastroenterology
  61. Trial Watch
    Erika Vacchelli, Alexander M.M. Eggermont, Catherine Sautès‐Fridman, Jérôme Galon, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi · 2013 · OncoImmunology
  62. Cervical Microbiota Associated with Higher Grade Cervical Intraepithelial Neoplasia in Women Infected with High-Risk Human Papillomaviruses
    Chandrika Jayanthi Piyathilake, Nicholas Jay Ollberding, Ranjit Kumar, Maurizio Macaluso, Ronald David Alvarez, Casey D. Morrow · 2016 · Cancer Prevention Research
  63. Role of gut microbiota in liver disease
    Somaya A. M. Albhaisi, Jasmohan Singh Bajaj, Arun Jayant Sanyal · 2019 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  64. Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
    Hiroshi Fukui · 2019 · Diseases
  65. The Gordian Knot of dysbiosis, obesity and NAFLD
    Wajahat Zafar Mehal · 2013 · Nature Reviews Gastroenterology & Hepatology
  66. Acute liver failure is regulated by MYC- and microbiome-dependent programs
    Aleksandra A. Kolodziejczyk, Sara Federici, Niv Zmora, Gayatree Mohapatra, Mally Dori-Bachash, Shanni Hornstein, Avner Leshem, Debby Reuveni, Ehud Zigmond, Ana Tobar et al. · 2020 · Nature Medicine
  67. Small Molecules Drive Big Improvements in Immuno‐Oncology Therapies
    Bayard R. Huck, Lisa Kötzner, Klaus Urbahns · 2017 · Angewandte Chemie International Edition
  68. Cross-Kingdom Chemical Communication Drives a Heritable, Mutually Beneficial Prion-Based Transformation of Metabolism
    Daniel F. Jarosz, Jessica C. S. Brown, Gordon A. Walker, Manoshi Sen Datta, W. Lloyd Ung, Alex K. Lancaster, Assaf Rotem, Amelia Chang, Gregory A. Newby, David A. Weitz et al. · 2014 · Cell
  69. Gut microbiome alterations in patients with stage 4 hepatitis C
    Abdelrahman Mahmoud, AbdelReheem Adel, Ahmed Osama EL-Gendy, Tamer Mohamed Essam, Ramy Karam Aziz · 2016 · Gut Pathogens
  70. The Rise of Gastrointestinal Cancers as a Global Phenomenon: Unhealthy Behavior or Progress?
    Sílvia Rodrigues Jardim, Lucila Marieta Perrotta de Souza, Heitor Siffert Pereira de Souza · 2023 · International Journal of Environmental Research and Public Health
  71. Carcinogenesis and therapeutics: the microbiota perspective
    Tsilimigras, Matthew C. B., Fodor, Anthony, Jobin, Christian · 2017 · Nature Microbiology
  72. Time for food: The impact of diet on gut microbiota and human health
    Na Zhang, Zhongjie Ju, Tao Zuo · 2018 · Nutrition
  73. Activation of TLR4 signaling promotes gastric cancer progression by inducing mitochondrial ROS production
    Xiang Yuan, Yunlan Zhou, W Wang, Jing Li, G Xie, Yong Zhao, Dakang Xu, Lisha Shen · 2013 · Cell Death and Disease
  74. Transplantation of human microbiota into conventional mice durably reshapes the gut microbiota
    Laura Wrzosek, Dragos Marius Ciocan, Patrick Borentain, Madeleine Spatz, Virginie Puchois, Cindy Hugot, Gladys Ferrere, Camille Mayeur, Gabriel Perlemuter, Anne‐Marie Cassard · 2018 · Scientific Reports
  75. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment
    Yanan Yu, TaChung Yu, Huijun Zhao, Tiantian Sun, Huimin Chen, Haoyan Chen, Hui-Fang An, Yurong Weng, Jun Qing Yu, Min Li et al. · 2015 · Oncotarget
  76. Stellate cells and the development of liver cancer: Therapeutic potential of targeting the stroma
    Cédric Coulouarn, Bruno Clément · 2014 · Journal of Hepatology
  77. Negative regulation of NF-κB p65 activity by serine 536 phosphorylation
    Jean‐Philippe Pradère, Céline Hernandez, Christiane Koppe, Richard A. Friedman, Tom Luedde, Robert F. Schwabe · 2016 · Science Signaling
  78. Microbiota, NASH, HCC and the potential role of probiotics
    Giovanni Brandi, Stefania De Lorenzo, Marco Candela, Maria A. Pantaleo, Stefano Bellentani, Francesco Tovoli, Gioconda Saccoccio, Guido Biasco · 2017 · Carcinogenesis
  79. The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies
    Marica Meroni, Miriam Longo, Paola Dongiovanni · 2019 · Nutrients
  80. Regulation of wound healing and organ fibrosis by toll-like receptors
    Peter Huebener, Robert F. Schwabe · 2012 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  81. Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma – The SHELTER study
    Michael Bitzer, Marius Horger, Edoardo Giovanni Giannini, Tom M. Ganten, Marcus‐Alexander Wörns, Jens Thomas Siveke, Matthias Dollinger, Guido Gerken, Max Ernst Scheulen, Henning Wege et al. · 2016 · Journal of Hepatology
  82. Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation
    Xueli Bian, Hang‐zi Chen, Pengbo Yang, Ying-ping Li, Fen-na Zhang, Jia-yuan Zhang, Wei-jia Wang, Wenxiu Zhao, Sheng Zhang, Qi-Tao Chen et al. · 2017 · Nature Communications
  83. Context-dependent functions of pattern recognition receptors in cancer
    Si Ming Man, Brendan John Jenkins · 2022 · Nature reviews. Cancer
  84. The microbiome and hepatobiliary-pancreatic cancers
    Kosuke Mima, Shigeki Nakagawa, Hiroshi Sawayama, Takatsugu Ishimoto, Katsunori Imai, Masaaki Iwatsuki, Daisuke Hashimoto, Yoshifumi Baba, Yo‐ichi Yamashita, Naoya Yoshida et al. · 2017 · Cancer Letters
  85. Role of Gut Microbiota in Hepatocarcinogenesis
    Haripriya Gupta, Gi Soo Youn, Min Jea Shin, Ki Tae Suk · 2019 · Microorganisms
  86. Inference of Network Dynamics and Metabolic Interactions in the Gut Microbiome
    Steven Nathaniel Steinway, Matthew B. Biggs, Thomas P. Loughran, Jason A. Papin, Réka Albert · 2015 · PLoS Computational Biology
  87. Dysbiosis of gut microbiota in patients with esophageal cancer
    YaLi Deng, Derong Tang, Pan‐Fei Hou, Weitao Shen, Huilin Li, Tian Wang, Ran Liu · 2020 · Microbial Pathogenesis
  88. Emerging Role of High-Mobility Group Box 1 (HMGB1) in Liver Diseases
    Ruochan Chen, Wen Hou, Qiuhong Zhang, Rui Kang, Xuegong Fan, Daolin Tang · 2013 · Molecular Medicine
  89. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models
    Iris Martinez-Quetglas, Roser Pinyol, Daniel Dauch, Sara Torrecilla, Victoria Tovar, Agrin Moeini, Clara Alsinet, Anna Portela, Leonardo Rodríguez‐Carunchio, Manel Solé et al. · 2016 · Gastroenterology
  90. Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma
    Ruipeng Zheng, Guoqiang Wang, Zhiqiang Pang, Nan Ran, Yinuo Gu, Xuewa Guan, Yuze Yuan, Xu Zuo, He Pan, Jingtong Zheng et al. · 2020 · Cancer Medicine
  91. The Microbiome as a Component of the Tumor Microenvironment
    Tündé Kovàcs, Edit Mikó, Gyula Ujlaki, Zsanett Sári, Péter Bai · 2020 · Advances in experimental medicine and biology
  92. Toll-like Receptors from the Perspective of Cancer Treatment
    Nasir Javaid, Sangdun Choi · 2020 · Cancers
  93. Deep sequencing reveals microbiota dysbiosis of tongue coat in patients with liver carcinoma
    Haifeng Lu, Zhigang Ren, Ang Li, Hua Zhang, Jianwen Jiang, Shaoyan Xu, Qixia Luo, Kai Zhou, Xiaoli Sun, Shusen Zheng et al. · 2016 · Scientific Reports
  94. Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma
    Alexander L. Gerbes, Fabien Zoulim, Herbert Tilg, Jean‐François Dufour, Jordi Bruix, Valérie Paradis, Riad Salem, Markus Peck‐Radosavljevic, Peter R. Galle, Tim F. Greten et al. · 2017 · Gut
  95. Microbiome in cancer: Role in carcinogenesis and impact in therapeutic strategies
    Md. Mominur Rahman, Md. Rezaul Islam, Sheikh Shohag, Md. Tanjimul Ahasan, Nadia Sarkar, Hosneara Khan, Alexandru Madalin Hasan, Simona Daniela Cavalu, Abdur Rauf · 2022 · Biomedicine & Pharmacotherapy
  96. Gut microbes as future therapeutics in treating inflammatory and infectious diseases: Lessons from recent findings
    Suprabhat Mukherjee, Nikhilesh Joardar, Subhasree Sengupta, Santi P. Sinha Babu · 2018 · The Journal of Nutritional Biochemistry
  97. Nanoparticle Conjugation of Ginsenoside Rg3 Inhibits Hepatocellular Carcinoma Development and Metastasis
    Zhigang Ren, Xinmei Chen, Liangjie Hong, Xiaoxiong Zhao, Guangying Cui, Ang Li, Yang Liu, Lina Zhou, Ranran Sun, Shen Shen et al. · 2019 · Small
  98. Gut‐liver axis‐mediated mechanism of liver cancer: A special focus on the role of gut microbiota
    Naoko Ohtani, Eiji Hara · 2021 · Cancer Science
  99. Gut microbiome and anticancer immune response: really hot Sh*t!
    Viaud, S, Daillère, R, Boneca, I G, Lepage, P, Langella, P, Chamaillard, M, Pittet, M J, Ghiringhelli, F, Trinchieri, G, Goldszmid, R et al. · 2015 · Cell Death & Differentiation
  100. A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature
    Mauro Giuffrè, Michele Campigotto, Giuseppina Campisciano, Manola Comar, Lory Saveria Crocè · 2020 · American Journal of Physiology-Gastrointestinal and Liver Physiology